One of the most commonly observed adverse effects of cyclosporin A (CsA) is the development of gingival overgrowth (GO). Fibroblasts are involved in GO, but the question why only a percentage of patients undergoing CsA treatment shows this side-effect remains unanswered. In a previous study, CsA has been demonstrated to induce over-expression of phospholipase C (PLC) beta(1) in fibroblasts of patients with clinical GO, in cells from both enlarged and clinically healthy gingival sites. In this work, we assessed the expression of PLC beta isoforms to investigate whether the exaggerated fibroblast response to CsA related to increased PLC beta(1) expression could also be detected in CsA-treated patients without clinical signs of GO. Our results support the hypothesis of a multi-factorial origin of gingival overgrowth, including specific changes within the gingival tissues orchestrating fibroblastic hyper-responsiveness as a consequence of a long-term in vivo exposure to cyclosporin A.
Cyclosporin A Specifically Affects Nuclear PLC{beta}1 in Immunodepressed Heart Transplant Patients with Gingival Overgrowth / Ruggeri A Jr.; Montebugnoli L.; Matteucci A.; Zini N.; Solimando L.; Servidio D.; Suppa P.; Cadenaro M.; Cocco L.; Breschi L.. - In: JOURNAL OF DENTAL RESEARCH. - ISSN 0022-0345. - STAMPA. - 84(8):(2005), pp. 747-751.
Cyclosporin A Specifically Affects Nuclear PLC{beta}1 in Immunodepressed Heart Transplant Patients with Gingival Overgrowth
RUGGERI, ALESSANDRA;MONTEBUGNOLI, LUCIO;SOLIMANDO, LILIANA;SERVIDIO, DORA;SUPPA, PIETRO;COCCO, LUCIO ILDEBRANDO;BRESCHI, LORENZO
2005
Abstract
One of the most commonly observed adverse effects of cyclosporin A (CsA) is the development of gingival overgrowth (GO). Fibroblasts are involved in GO, but the question why only a percentage of patients undergoing CsA treatment shows this side-effect remains unanswered. In a previous study, CsA has been demonstrated to induce over-expression of phospholipase C (PLC) beta(1) in fibroblasts of patients with clinical GO, in cells from both enlarged and clinically healthy gingival sites. In this work, we assessed the expression of PLC beta isoforms to investigate whether the exaggerated fibroblast response to CsA related to increased PLC beta(1) expression could also be detected in CsA-treated patients without clinical signs of GO. Our results support the hypothesis of a multi-factorial origin of gingival overgrowth, including specific changes within the gingival tissues orchestrating fibroblastic hyper-responsiveness as a consequence of a long-term in vivo exposure to cyclosporin A.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
